Crassolide Suppresses Dendritic Cell Maturation and Attenuates Experimental Antiphospholipid Syndrome

Antiphospholipid syndrome (APS) is an autoimmune disease characterized by the production of β2-glycoprotein I (β2GPI)-dependent autoantibodies, with vascular thrombosis or obstetrical complications. Around 20% of APS patients are refractory to current treatments. Crassolide, a cembranoid diterpene extracted from soft corals, is a potential therapeutic candidate. Here, to examine the anti-inflammatory properties of crassolide, we first determined its effects on bone marrow-derived and splenic dendritic cells (DC). Specifically, we applied lipopolysaccharide (LPS) or β2GPI stimulation and measured the expressions of CD80 and CD86, and secretions of cytokines. We also determined in the OT-II mice, if bone marrow-derived DC was able to stimulate antigen-specific T cells. Moreover, we examined the therapeutic potential of crassolide postimmunization in a murine model of APS that depended on active immunization with β2GPI. The vascular manifestations were evaluated in terms of fluorescein-induced thrombi in mesenteric microvessels, whereas the obstetric manifestations were evaluated based on the proportion of fetal loss after pregnancy. We also measured blood titers of anti-β2GPI antibody, splenic cell proliferative responses and cytokine secretions after β2GPI stimulation ex vivo. Finally, we determined in these mice, hematological, hepatic and renal toxicities of crassolide. Crassolide after LPS stimulation suppressed DC maturation and secretion of tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-12 and IL-23, and downstream T cell activation. Crassolide could partially ameliorate both the vascular and obstetric manifestations of APS in BALB/c mice. Both blood titers of anti-β2GPI antibody and splenic cell proliferation after β2GPI stimulation were reduced. Splenic Th1 and Th17 responses were also lowered after β2GPI stimulation. Finally, within therapeutic doses of crassolide, we found no evidence of its toxicity. In conclusion, we showed the ability of crassolide to suppress DC and downstream T cell responses. Crassolide is therefore a potential candidate for adjunctive therapy in APS.     

Synthesis and characterization of folic acid‐modified carboxymethyl chitosan‐ursolic acid targeted nano‐drug carrier for the delivery of ursolic acid and 10‐hydroxycamptothecin

Carboxymethyl chitosan (CMCS), as a water‐soluble, biocompatible, and biodegradable polymer, is an excellent carrier for a sustained drug delivery system. In this study, a amphiphilic carboxymethyl chitosan‐ursolic acid nano‐drug carrier modified by folic acid (FPCU) were prepared, and then the nano‐drug carrier wrapped another anticancer drug 10‐hydroxycamptothecin were self‐assembled into nanoparticles (FPCU/HCPT NPs). The FPCU/HCPT NPs had a suitable size, high drug loading efficiency of ursolic acid (6.4%) and 10‐hydroxycamptothecin (14.1%). The drug release study in vitro indicated that the nanoparticles have obviously sustained effect and pH sensitive behaviors, the drug release amount was higher at pH 5.5 than at pH 7.4. in vitro and in vivo study showed that the nanoparticles displayed a high antitumor efficiency to tumor cells compared with free drug. The nano delivery system as a carrier for ursolic acid (UA) and 10‐hydroxycamptothecin (HCPT) has good application prospects in cancer treatment.     

Residue valorization: Preparation of recyclable organic amine adsorbent using laterite residue

This study focuses on exploiting the main component of traditional nickel metallurgical waste for use as a valuable material that can be applied in the removal of organic amines from water systems. Silicon compounds from metallurgic waste were converted into dissolvable sodium silicate by roasting the waste with alkali. Silica with adsorption capacity was combined with magnetic NiFe cores by the carbonation decomposition of purified silicate solution. The composite magnetic adsorbent was characterized, and its adsorption mechanism for organic amines was investigated. The effects of the initial trimethylamine concentration, contact time and temperature on the adsorption efficiency of the composite adsorbent towards trimethylamine were investigated. It was found that the adsorption fit the Freundlich mode well. The adsorption kinetics can be described by a pseudo-second-order kinetic model. The adsorption capacity reached 55.8 μg/mg at 293 K. The use of metallurgical waste to prepare the magnetic composite adsorbent has three advantages, which include benefiting the environment by reducing the amount of solid waste and costs associated with constructing and maintaining storage facilities, generating valuable products in an economical manner and conveniently recycling used adsorbents to avoid secondary pollution.     

Janus 粒子在环境检测领域中的应用

Janus 粒子,也称为阴阳结构粒子或两面性非对称粒子,是指表面上具有两种或两种以上不同化学组成或性质的不对称粒子。目前,Janus 粒子因其独特的结构和功能已经逐渐成为生物医药、催化、材料以及防污等领域中的新型功能材料。在环境检测领域,Janus材料亦因其特殊的光学、磁学及电学性能,为提高检测灵敏度、选择性和稳定性等提供了新的研究方向。基于此,本文主要讨论了Janus材料在环境检测方面的特点、优势和相关应用。最后,本文基于本课题组的研究经验以及工作中所面临的问题,对本领域的发展和未来的研究方向提出了展望,以期对本领域的未来发展提供指导。     

Moracin M的简便合成及其生物活性研究

本文以4-甲氧基水杨醛和3,5-二甲氧基溴化苄为原料,经取代、缩合和水解等3步反应,以38%的总收率合成了Moracin M。分别采用DPPH自由基清除法、小鼠巨噬细胞RAW264.7模型初步测试了Moracin M的抗氧化活性和体外抗炎活性,结果表明该化合物对DPPH自由基的清除能力很强（IC₅₀=0.0433mg/mL）,优于阳性对照药V_C,且具有一定的抗炎活性。      

基于核酸的纸基荧光生物传感器的设计及应用

纸基生物传感器由于其具有成本低、操作方便、生物可降解、识别元件用量低等优点,近年来受到了广泛的关注。其中,以功能核酸作为识别元件的纸基荧光生物传感器具有较高的灵敏度、瞬时响应以及实时检测等特性,在便携式传感设备方面展现出巨大的潜力。此外,将核酸作为识别元件的纸基无细胞蛋白合成平台,通过条件合成的报告荧光蛋白可实现对病毒、重金属等目标物的特异性检测,具有良好的应用前景。首先,本文介绍了基于核酸的纸基荧光生物传感器的设计,特别是基于核酸的识别元件与纸基材料的结合方式。其次,总结了基于核酸的纸基荧光生物传感器在临床诊断、食品安全检测、环境污染物检测等不同领域的最新研究进展,讨论了其优势与局限性。最后,探讨了基于核酸的纸基荧光生物传感器的发展方向与应用前景,以期为相关领域的研究提供参考。     

A Cyanine-based Liposomal Nanophotosensitizer for Enhanced Cancer Chemo-Photodynamic Therapy

Currently, chemotherapy is one of the most important treatment modalities for malignant tumors in the clinic, however, it exhibits some shortcomings, such as poor selectivity, limited efficacy and serious adverse effects. Therefore, synergistic therapy and accurate drug delivery at tumor sites become a promising strategy for achieving tumor eradication. Herein, a smart NIR fluorescence imaging-guided nanoliposome was fabricated by encapsulating a chemotherapeutic drug(doxorubicin, DOX), liposomes(L) and a near-infrared(NIR) photosensitizer(CY) to form L@CY@DOX, which could realize enhanced therapeutic efficacy of chemo-PDT in cancer therapy(PDT=photodynamic therapy). L@CY@DOX can induce mitochondrial apoptosis and produce severe toxicity at the cellular level, and L@CY@DOX can enrich in the tumor site, which significantly induces tumor death. In vitro and in vivo studies demonstrated that L@CY@DOX exhibited great antitumor efficacy compared with each one of these monotherapies, indicating that the combination of chemotherapy and PDT possessed potential development prospects and is anticipated in clinical application.     

State-crossing from a Locally Excited to an Electron Transfer State(SLEET) Model Rationalizing the Aggregation-induced Emission Mechanism of (Bi)piperidylanthracenes

Luminogens with aggregation-induced emission(AIE)characteristics(or AIEgens)have been widely used in various applications due to their excellent luminescent properties in molecular aggregates and the solid state.A deep understanding of the AIE mechanism is critical for the rational development of AIEgens.In this work,the“state-crossing from a locally excited to an electron transfer state”(SLEET)model is employed to rationalize the AIE phenomenon of two(bi)piperidylanthracenes.According to the SLEET model,an electron transfer(ET)state is formed along with the rotation of the piperidyl group in the excited state of(bi)piperidylan-thracene monomers,leading to fluorescence quenching.In contrast,a bright state exists in the crystal and molecular aggregates of these compounds,as the intermolecular interactions restrict the formation of the dark ET state.This mechanistic understanding could inspire the deployment of the SLEET model in the rational designs of various functional AIEgens.     

MOFs/水凝胶复合材料的制备及其应用研究

金属有机框架(MOFs)具有大量的孔隙结构和活性位点,在气体吸附、催化、医疗等领域均发挥了巨大的作用。MOFs是晶体粉末,具有脆性较大、在水中易分解和不易回收等缺点,从而限制了其应用。通过MOFs与柔性高分子的复合,特别是与水凝胶的复合,极大地改善了复合材料的柔顺性、可回收和可加工性等特性,进一步拓宽了MOFs的应用领域。本文详细阐述了基于水凝胶MOFs原位生成法、MOFs /水凝胶同时生成法和水凝胶包裹MOFs法等三种不同方法制备MOFs/水凝胶复合材料的研究进展,并对上述三种制备方法的特点及其产物特征进行了总结,进一步归纳了复合材料在生物医药、催化、废水处理和气体吸附等领域的应用。最后,对MOFs/水凝胶复合材料制备方法的改进和复合材料应用前景进行了深入讨论和展望。